BioScrip Pharmacy (NY), Inc.

483 response sent October 10, 2014 · Jamaica, New York

Inspection: Sep 10 – Sep 19, 2014
Investigator: James A. Liubicich
Pages: 21
FEI number: 3011022663

In short: This is BioScrip Pharmacy (NY), Inc.'s written response to FDA, dated October 10, 2014, for its site in Jamaica, New York (FEI 3011022663). It sets out the corrective actions the firm committed to.

Inside this response

The full response

Every page of the response, exactly as written.

Get the full response

This inspection in context

The investigator

James A. Liubicich

13 documents · 2013–2015

Cites 211.42 (design and construction features) more than any other section. Most of their documents are for sites in New York.

The firm

BioScrip Pharmacy (NY), Inc. history

All 2 documents on file for this site, in date order, with what was cited at each inspection.

Questions about this response

Who inspected BioScrip Pharmacy (NY), Inc.?

James A. Liubicich is named on this 483 response, for the inspection of Sep 10 – Sep 19, 2014. Each investigator has a profile showing what they cite most.

When was BioScrip Pharmacy (NY), Inc. inspected by FDA?

The inspection ran Sep 10 – Sep 19, 2014, and the 483 response is dated October 10, 2014.

How do I get the full 483 response for BioScrip Pharmacy (NY), Inc.?

Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.